Dr. Kathrin U. Jansen, Ph.D.
Kathrin U. Jansen, Ph.D., is the Senior Vice President and Head of Vaccine Research and Development (VRD) at Pfizer Inc, and a member of Pfizer's Worldwide Research and Development leadership team. Dr. Jansen leads a fully integrated, global vaccines research and development organization, with responsibilities ranging from discovery to registration and post-marketing commitments and a clinical vaccines portfolio that includes vaccines to prevent or treat diseases of significant unmet medical need such as Staphylococcus aureus, Clostridium difficile, Group B stretococcus and prostate cancer. More recent accomplishments are the global licensures of Prev(e)nar13 ®
to prevent pneumococcal diseases and the development and licensure of Trumenba®
the first vaccine licensed in the United States to prevent invasive disease caused by Neisseria meningitidis serogroup B.
